Search Results - "Chel Hun Choi"

Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan.

Authors: Chel-Hun Choi Yoo-Young Lee Yen-Ling Lai et al.

Source: Journal of Gynecologic Oncology. Mar2025, Vol. 36 Issue 2, p1-11. 11p.

Transition and prognostic implications of 2009 to 2023 FIGO staging in endometrial cancer: a retrospective cohort study from stage I to IIIA.

Authors: Chel-Hun Choi Jun-Hyeong Seo Yoo-Young Lee et al.

Source: Journal of Gynecologic Oncology. 2024 Supplement, Vol. 35, p53-54. 2p.

Preliminary efficacy of pembrolizumab plus lenvatinib in recurrent clear cell gynecological cancer: Phase II LARA trial (GCGS-OV4/APGOT-OV3).

Authors: Byoung-Gie Kim Chel Hun Choi Ngoi, Natalie et al.

Source: Journal of Gynecologic Oncology. 2024 Supplement, Vol. 35, p31-32. 2p.

DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).

Authors: Chel Hun Choi Ray-Coquard, Isabelle Rubio, Maria Jesus et al.

Source: Journal of Gynecologic Oncology. 2024 Supplement, Vol. 35, p19-20. 2p.

Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy.

Authors: Maria Lee Chel Hun Choi Yi Kyeong Chun et al.

Source: Journal of Gynecologic Oncology. Jan2017, Vol. 28 Issue 1, p1-8. 8p.

Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.

Authors: Chel Hun Choi Joon-Yong Chung Eun Joo Chung et al.

Source: BMC Cancer. 7/11/2016, Vol. 16, p1-11. 11p. 2 Diagrams, 2 Charts, 3 Graphs.

Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.

Authors: Chel Hun Choi Joon-Yong Chung Jae-Hoon Kim et al.

Source: Journal of Translational Medicine. 5/6/2016, Vol. 14, p1-12. 12p.

Significance of HPV status on tumor response and treatment outcomes in endocervical adenocarcinoma treated with definitive chemoradiotherapy: a retrospective study.

Authors: Jong Yun Baek Hyun-Soo Kim Won Kyung Cho et al.

Source: Journal of Gynecologic Oncology. Nov2025, Vol. 36 Issue 6, p1-11. 11p.

Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival.

Authors: Kyoung Won Noh Bomi Kim Chel Hun Choi et al.

Source: Cancer Research & Treatment. Jan2022, Vol. 54 Issue 1, p245-252. 8p.

Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma.

Authors: Young-Ae Park Chel Hun Choi In-Gu Do et al.

Source: Gynecologic Oncology. Oct2014, Vol. 135 Issue 1, p108-117. 10p.

Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer.

Authors: Chel Hun Choi Yoo-Young Lee Tae-Jong Song et al.

Source: Cancer (0008543X). 5/15/2011, Vol. 117 Issue 10, p2104-2111. 8p. 6 Charts, 2 Graphs.

Prognostic significance of p-STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.

Authors: Chel Hun Choi Sang Yong Song Heeseok Kang et al.

Source: Journal of Obstetrics & Gynaecology Research. Apr2010, Vol. 36 Issue 2, p304-310. 7p. 1 Black and White Photograph, 2 Charts, 1 Graph.

Oncologic outcomes and the impact of minimally invasive surgery in early-stage cervical cancer patients undergoing radical trachelectomy: a Korean Gynecologic Oncology Group study (KGOG 1048).

Authors: Ju-Hyun Kim Dae-Yeon Kim Chel Hun Choi et al.

Source: Journal of Gynecologic Oncology. 2024 Supplement, Vol. 35, p66-67. 2p.

Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines.

Authors: Banghyun Lee Suk-Joon Chang Byung Su Kwon et al.

Source: Journal of Gynecologic Oncology. Jan2025, Vol. 36 Issue 1, p1-8. 8p.

Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial).

Authors: Bo Seong Yun Kwang-Beom Lee Keun Ho Lee et al.

Source: Journal of Gynecologic Oncology. Sep2024, Vol. 35 Issue 5, p1-11. 11p.

Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis.

Authors: Paik, E. Sun Tae-Joong Kim Chel Hun Choi et al.

Source: Journal of Gynecologic Oncology. Mar2018, Vol. 29 Issue 2, p1-11. 11p.

Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.

Authors: Bo Wook Kim Hanbyoul Cho Chel Hun Choi et al.

Source: BMC Cancer. 12/26/2015, Vol. 15, p1-8. 8p. 1 Color Photograph, 4 Charts, 1 Graph.

Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines.

Authors: Banghyun Lee Suk-Joon Chang Byung Su Kwon et al.

Source: Journal of Gynecologic Oncology. Jan2024, Vol. 35 Issue 1, p1-12. 12p.

Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array.

Authors: Braunschweig, Till Joon-Yong Chung Chel Hun Choi et al.

Source: Diagnostic Pathology. 6/12015, Vol. 10 Issue 1, p1-10. 10p.

Histologic distribution of borderline ovarian tumors worldwide: a systematic review.

Authors: Taejong Song Yoo-Young Lee Chel Hun Choi et al.

Source: Journal of Gynecologic Oncology. Mar2013, Vol. 24 Issue 1, p44-51. 8p.